Literature DB >> 33570737

Radiotherapy-Specific Chronic Pain Syndromes in the Cancer Population: An Evidence-Based Narrative Review.

Jay Karri1, Laura Lachman1, Alex Hanania2, Anuj Marathe1, Mani Singh3, Nicholas Zacharias4, Vwaire Orhurhu5, Amitabh Gulati6, Alaa Abd-Elsayed7.   

Abstract

While radiation therapy is increasingly utilized in the treatment paradigm of many solid cancers, the chronic effects of radiation therapies are poorly characterized. Notably, understanding radiation-specific chronic pain syndromes is paramount given that the diagnosis and management of these conditions can serve to prevent long-standing functional impairments, optimize quality of life, and even allow for continued radiotherapy candidacy. These radiation-specific chronic pain phenomena include dermatitis, mucositis, enteritis, connective tissue fibrosis, lymphedema, and neuropathic pain syndromes. It is necessary to maintain a low threshold of suspicion for appropriately diagnosing these conditions as there exists a variance in when these symptoms arise after radiation. However, we present key epidemiological data delineating vulnerable cancer populations for each pain syndrome along with the available evidence for the management for each specific condition.

Entities:  

Keywords:  Cancer; Chronic pain; Multidisciplinary pain management; Radiotherapy

Mesh:

Year:  2021        PMID: 33570737     DOI: 10.1007/s12325-021-01640-x

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  120 in total

1.  Use of normal tissue complication probability models in the clinic.

Authors:  Lawrence B Marks; Ellen D Yorke; Andrew Jackson; Randall K Ten Haken; Louis S Constine; Avraham Eisbruch; Søren M Bentzen; Jiho Nam; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Pain in cancer survivors.

Authors:  Matthew Rd Brown; Juan D Ramirez; Paul Farquhar-Smith
Journal:  Br J Pain       Date:  2014-11

3.  Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030.

Authors:  Alex K Bryant; Matthew P Banegas; Maria Elena Martinez; Loren K Mell; James D Murphy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-17       Impact factor: 4.254

Review 4.  Recent Developments in Radiotherapy.

Authors:  Deborah E Citrin
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

Review 5.  Chronic pain in the cancer survivor: a new frontier.

Authors:  Allen W Burton; Gilbert J Fanciullo; Ralph D Beasley; Michael J Fisch
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

Review 6.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

Review 7.  Pelvic Radiation and Normal Tissue Toxicity.

Authors:  Sarah Nicholas; Linda Chen; Amanda Choflet; Amanda Fader; Zachary Guss; Sarah Hazell; Daniel Y Song; Phuoc T Tran; Akila N Viswanathan
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

Review 8.  Management of Radiation Toxicity in Head and Neck Cancers.

Authors:  Farzan Siddiqui; Benjamin Movsas
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

Review 9.  Thoracic Radiation Normal Tissue Injury.

Authors:  Charles B Simone
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

10.  Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration.

Authors:  A Ram Doo; Yu Seob Shin; Seonwoo Yoo; Jong Kwan Park
Journal:  J Pain Res       Date:  2018-03-15       Impact factor: 3.133

View more
  1 in total

1.  Radioprotective and Radiomitigative Effects of Melatonin in Tissues with Different Proliferative Activity.

Authors:  Serazhutdin A Abdullaev; Sergey I Glukhov; Azhub I Gaziev
Journal:  Antioxidants (Basel)       Date:  2021-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.